The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
The Versatile Mutational Resistome of Pseudomonas aeruginosa
Open accessAbstract
One of the most striking features of Pseudomonas aeruginosa is its outstanding capacity for developing antimicrobial resistance to nearly all available antipseudomonal agents through the selection of chromosomal mutations, leading to the failure of the treatment of severe hospital-acquired or chronic infections. Recent Whole Genome Sequence (WGS) data obtained from in vitro assays on the evolution of antibiotic resistance, in vivo monitoring of antimicrobial resistance development, analysis of sequential cystic fibrosis isolates, and characterization of widespread epidemic high-risk clones have provided new insights into the evolutionary dynamics and mechanisms of P. aeruginosa antibiotic resistance, thus motivating this review. Indeed, the analysis of the WGS mutational resistome has proven to be useful for understanding the evolutionary dynamics of classical resistance pathways and to describe new mechanisms for the majority of antipseudomonal classes, including β-lactams, aminoglycosides, fluoroquinolones or polymixins. Beyond addressing a relevant scientific question, the analysis of the P. aeruginosa mutational resistome is expected to be useful, together with the analysis of the horizontally-acquired resistance determinants, for establishing the antibiotic resistance genotype, which should correlate with the antibiotic resistance phenotype and as such, it should be useful for the design of therapeutic strategies and for monitoring the efficacy of administered antibiotic treatments. However, further experimental research and new bioinformatics tools are still needed to overcome the interpretation limitations imposed by the complex interactions (including those leading to collateral resistance or susceptibility) between the hundreds of genes involved in the mutational resistome, as well as the frequent difficulties for differentiating relevant mutations from simple natural polymorphisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Self-citationMechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Nosocomial infections in adult intensive-care units
Vincent, J.-L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13644-6 · Cited by 705
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Self-citationResistance to polymyxins in Gram-negative organisms
Jeannot, K., Bolard, A., & Plésiat, P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.11.029 · Cited by 402
Michalopoulos, A. S., Livaditis, I. G., & Gougoutas, V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.07.007 · Cited by 378
The Neglected Intrinsic Resistome of Bacterial Pathogens
Fajardo, A., Martínez-Martín, N., Mercadillo, M., Galán, J. C., Ghysels, B., Matthijs, S., Cornelis, P., Wiehlmann, L., Tümmler, B., Baquero, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001619 · Cited by 367
Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3382-3386.2005 · Cited by 309
Self-citationβ-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Self-citationHaidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Collateral sensitivity of antibiotic-resistant microbes
Pál, C., Papp, B., & Lázár, V. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.02.009 · Cited by 270
Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-15 · Cited by 268
The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility
Kos, V. N., Déraspe, M., McLaughlin, R. E., Whiteaker, J. D., Roy, P. H., Alm, R. A., Corbeil, J., & Gardner, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03954-14 · Cited by 264
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
Self-citationMoskowitz, S. M., Brannon, M. K., Dasgupta, N., Pier, M., Sgambati, N., Miller, A. K., Selgrade, S. E., Miller, S. I., Denton, M., Conway, S. P., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05829-11 · Cited by 230
Castanheira, M., Deshpande, L. M., Costello, A., Davies, T. A., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku048 · Cited by 208
Cabot, G., Zamorano, L., Moyá, B., Juan, C., Navas, A., Blázquez, J., & Oliver, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02676-15 · Cited by 208
Self-citationFraile-Ribot, P. A., Cabot, G., Mulet, X., Periañez, L., Martín-Pena, M. L., Juan, C., Pérez, J. L., & Oliver, A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx424 · Cited by 207
Self-citationLahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Markussen, T., Marvig, R. L., Gómez-Lozano, M., Aanæs, K., Burleigh, A. E., Høiby, N., Johansen, H. K., Molin, S., & Jelsbak, L. (2014) · mBio · doi:10.1128/mbio.01592-14 · Cited by 179
Juan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Self-citationdel Barrio-Tofiño, E., López-Causapé, C., Cabot, G., Rivera, A., Benito, N., Segura, C., Montero, M. M., Sorlí, L., Tubau, F., Gómez-Zorrilla, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01589-17 · Cited by 170
Self-citationHan, S., Zaniewski, R. P., Marr, E. S., Lacey, B. M., Tomaras, A. P., Evdokimov, A., Miller, J. R., & Shanmugasundaram, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013092107 · Cited by 166
Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections
Imamovic, L., Ellabaan, M. M. H., Dantas Machado, A. M., Citterio, L., Wulff, T., Molin, S., Krogh Johansen, H., & Sommer, M. O. A. (2018) · Cell · doi:10.1016/j.cell.2017.12.012 · Cited by 165
Alvarez-Ortega, C., Wiegand, I., Olivares, J., Hancock, R. E. W., & Martínez, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00257-10 · Cited by 164
Barrow, K., & Kwon, D. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00893-09 · Cited by 162
López-Causapé, C., Sommer, L. M., Cabot, G., Rubio, R., Ocampo-Sosa, A. A., Johansen, H. K., Figuerola, J., Cantón, R., Kidd, T. J., Molin, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05621-5 · Cited by 158
Self-citationMolecular Characterization of an Epidemic Clone of Panantibiotic-ResistantPseudomonas aeruginosa
Deplano, A., Denis, O., Poirel, L., Hocquet, D., Nonhoff, C., Byl, B., Nordmann, P., Vincent, J., & Struelens, M. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1198-1204.2005 · Cited by 146
Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosa
Schurek, K. N., Marr, A. K., Taylor, P. K., Wiegand, I., Semenec, L., Khaira, B. K., & Hancock, R. E. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00507-08 · Cited by 146
Bruchmann, S., Dötsch, A., Nouri, B., Chaberny, I. F., & Häußler, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-12 · Cited by 144
Caballero, J. D., Clark, S. T., Coburn, B. A., Zhang, Y., Wang, P. W., Donaldson, S. L., Tullis, D. E., Yau, Y. C. W., Waters, V. J., Hwang, D. M., et al. (2015) · mBio · doi:10.1128/mbio.00981-15 · Cited by 140
Dötsch, A., Becker, T., Pommerenke, C., Magnowska, Z., Jänsch, L., & Häußler, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-09 · Cited by 137
Cabot, G., López-Causapé, C., Ocampo-Sosa, A. A., Sommer, L. M., Domínguez, M. Á., Zamorano, L., Juan, C., Tubau, F., Rodríguez, C., Moyá, B., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01720-16 · Cited by 132
Self-citationGutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E., Kaul, R., Johansen, H. K., Høiby, N., & Moskowitz, S. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02353-12 · Cited by 131
Bagge, N., Ciofu, O., Hentzer, M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3406-3411.2002 · Cited by 121
Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01252-13 · Cited by 119
Döring, G., Parameswaran, G. I., & Murphy, T. F. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00237.x · Cited by 116
The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa
Castañeda-García, A., Rodríguez-Rojas, A., Guelfo, J. R., & Blázquez, J. (2009) · Journal of Bacteriology · doi:10.1128/jb.00748-09 · Cited by 116
Yen, P., & Papin, J. A. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001586 · Cited by 110
Juan, C., Torrens, G., González-Nicolau, M., & Oliver, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux043 · Cited by 99
Self-citationJorth, P. A., McLean, K., Ratjen, A., Secor, P. R., Bautista, G. E., Ravishankar, S., Rezayat, A., Garudathri, J., Harrison, J. J., Harwood, R. A., et al. (2017) · mBio · doi:10.1128/mbio.00517-17 · Cited by 97
Vestergaard, M. R., Paulander, W., Marvig, R. L., Clasen, J., Jochumsen, N., Molin, S., Jelsbak, L., Ingmer, H., & Folkesson, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.09.014 · Cited by 95
Fournier, D., Richardot, C., Müller, E., Robert-Nicoud, M., Llanes, C., Plésiat, P., & Jeannot, K. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt098 · Cited by 90
Dößelmann, B., Willmann, M., Steglich, M., Bunk, B., Nübel, U., Peter, S., & Neher, R. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00043-17 · Cited by 90
Bolard, A., Plésiat, P., & Jeannot, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01835-17 · Cited by 86
Chung, J. C. S., Becq, J., Fraser, L. J., Schulz-Trieglaff, O. B., Bond, N. J., Foweraker, J. E., Bruce, K. D., Smith, G. P., & Welch, M. (2012) · Journal of Bacteriology · doi:10.1128/jb.01050-12 · Cited by 85
Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa
Chen, W., Zhang, Y., & Davies, C. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01651-16 · Cited by 82
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
Skiada, A., Markogiannakis, A., Plachouras, D., & Daikos, G. L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.019 · Cited by 80
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy
Bassetti, M., Taramasso, L., Giacobbe, D. R., & Pelosi, P. P. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.36 · Cited by 80
Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa
Jaillard, M., van Belkum, A., Cady, K. C., Creely, D., Shortridge, D., Blanc, B., Barbu, E. M., Dunne, W. M., Zambardi, G., Enright, M. C., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.02.026 · Cited by 74
Feng, Y., Jonker, M. J., Moustakas, I., Brul, S., & ter Kuile, B. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00434-16 · Cited by 71
López-Causapé, C., Rubio, R., Cabot, G., & Oliver, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02583-17 · Cited by 69
Self-citationSuarez, C., Peña, C., Arch, O., Domínguez, M. Á., Tubau, F., Juan, C., Gavaldà, L., Sora, M., Oliver, A., Pujol, M., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-272 · Cited by 65
Self-citationMolecular characterization of Rifr mutations in Pseudomonas aeruginosa and Pseudomonas putida
Jatsenko, T., Tover, A., Tegova, R., & Kivisaar, M. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.10.015 · Cited by 63
Hocquet, D., Petitjean, M., Rohmer, L., Valot, B., Kulasekara, H. D., Bedel, E., Bertrand, X., Plésiat, P., Köhler, T., Pantel, A., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13336 · Cited by 61
Lau, C. H., Krahn, T., Gilmour, C., Mullen, E., & Poole, K. (2014) · MicrobiologyOpen · doi:10.1002/mbo3.226 · Cited by 57
Prickett, M. H., Hauser, A. R., McColley, S. A., Cullina, J. F., Potter, E., Powers, C., & Jain, M. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-208027 · Cited by 57
Greipel, L., Fischer, S., Klockgether, J., Dorda, M., Mielke, S., Wiehlmann, L., Cramer, N., & Tümmler, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00724-16 · Cited by 43
Rodríguez-Rojas, A., Macia, M. D., Couce, A., Gómez, C., Castañeda-García, A., Oliver, A., & Blázquez, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010193 · Cited by 42
Self-citationJuarez, P., Broutin, I., Bordi, C., Plésiat, P., & Llanes, C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02445-17 · Cited by 33
Cited by
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Self-citationAntibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution
Botelho, J., Grosso, F., & Peixe, L. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.07.002 · Cited by 550
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
del Barrio-Tofiño, E., López-Causapé, C., & Oliver, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106196 · Cited by 372
Self-citation
Metadata
- Authors
- López-Causapé, C., Cabot, G., del Barrio-Tofiño, E., & Oliver, A.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-06
- Volume
- 9
- Pages
- 685-685
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2804230504
- Cited by
- 254
- References
- 64
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.